GEHC · GE HealthCare Technologies Inc. · Executive Compensation

$71.98 +0.53 (+0.74%) At close · Oct 26

S&P 500 member Nasdaq-100 member Russell 1000 member Rebalance outlook locked

Market Cap

$32.50B

454.89M

Volume · Oct 26 2.87M Avg daily vol (3M) 3.64M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter J. Arduini	President & CEO	$1,250,000	$0	$2,099,996	—	$890,625	$120,520	$10,497,102
Peter Arduini	CEO	$1,250,000	$0	$2,099,996	—	$890,625	$120,520	$10,497,102
Frank R. Jimenez	General Counsel & Corporate Secretary	$728,571	$0	$0	—	$458,483	$664,485	$7,013,970
Betty D. Larson	Chief People Officer	$541,667	$675,000	$0	—	$290,421	$272,918	$6,008,959

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Helmut Zodl	Chief Financial Officer	$687,500	$1,812,500	$3,150,427	—	$0	$169,881	$5,820,308

Executive changes

Person	Role	Change	Effective	Filed
Pascal Desroches	director	Appointed	2027-01-04	2026-09-22
William K. Grogan	Chief Financial Officer	Appointed	2026-09-14	2026-08-18
George Newcomb	interim Chief Financial Officer	Appointed	2026-08-14	2026-07-23
James K. (Jay) Saccaro	Chief Financial Officer	Resigned	2026-08-14	2026-07-23
Kevin A. Lobo	director	Appointed	2026-03-13	2026-03-17
Lloyd W. Howell, Jr.	Board of Directors	Resigned	2025-07-23	2025-07-24
Jan Makela	Chief Executive Officer, Imaging	Resigned	2024-07-08	2024-04-15
Betty D. Larson	Chief People Officer	Resigned	2024-03-21	2024-02-05
Helmut Zodl	Global Vice President, Special Projects and TSA Separation	Appointed	2023-06-01	2023-05-09
James K. (Jay) Saccaro	Vice President and Chief Financial Officer	Appointed	2023-06-01	2023-05-09
Phoebe L. Yang	Director	Appointed	2023-01-03	2023-01-04
Risa Lavizzo-Mourey	Director	Appointed	2023-01-03	2023-01-04
William J. Stromberg	Director	Appointed	2023-01-03	2023-01-04
Tomislav Mihaljevic	Director	Appointed	2023-01-03	2023-01-04
Anne T. Madden	Director	Appointed	2023-01-03	2023-01-04
Catherine Lesjak	Director (Chair)	Appointed	2023-01-03	2023-01-04
Lloyd W. Howell, Jr.	Director	Appointed	2023-01-03	2023-01-04
Rodney F. Hochman	Director	Appointed	2023-01-03	2023-01-04
Peter J. Arduini	Director	Appointed	2023-01-03	2023-01-04
H. Lawrence Culp, Jr.	Director	Appointed	2023-01-03	2023-01-04
Thomas J. Westrick	CEO, Patient Care Solutions	Appointed	2023-01-03	2023-01-04
Roland Rott	CEO, Ultrasound	Appointed	2023-01-03	2023-01-04
Jan Makela	CEO, Imaging	Appointed	2023-01-03	2023-01-04
Kevin M. O'Neill	CEO, Pharmaceutical Diagnostics	Appointed	2023-01-03	2023-01-04
Betty D. Larson	Chief People Officer	Appointed	2023-01-03	2023-01-04

Leadership

Peter J. Arduini CEO, Board Member
Catherine Lesjak Chairman, Board Member
George Newcomb CFO, Chief Accounting Officer
James K. (Jay) Saccaro CFO
William K. Grogan CFO
Frank R. Jimenez General Counsel
George A. Newcomb Chief Accounting Officer
Anne T. Madden Board Member
H. Lawrence Culp, Jr. Board Member
Kevin A. Lobo Board Member
Lloyd W. Howell, Jr. Board Member
Michael J. Holston Board Member
Pascal Desroches Board Member
Phoebe L. Yang Board Member
Risa Lavizzo-Mourey Board Member
Rodney F. Hochman Board Member
Tomislav Mihaljevic Board Member
William J. Stromberg Board Member

Key facts CIK 1932393 CUSIP 36266G107 13F (30d) 318 filings 292 filers Visit website Investor relations